203 related articles for article (PubMed ID: 22610781)
1. Walker 256 tumour cells increase substance P immunoreactivity locally and modify the properties of the blood-brain barrier during extravasation and brain invasion.
Lewis KM; Harford-Wright E; Vink R; Nimmo AJ; Ghabriel MN
Clin Exp Metastasis; 2013 Jan; 30(1):1-12. PubMed ID: 22610781
[TBL] [Abstract][Full Text] [Related]
2. Treatment with the NK1 antagonist emend reduces blood brain barrier dysfunction and edema formation in an experimental model of brain tumors.
Harford-Wright E; Lewis KM; Ghabriel MN; Vink R
PLoS One; 2014; 9(5):e97002. PubMed ID: 24818961
[TBL] [Abstract][Full Text] [Related]
3. Tesmilifene modifies brain endothelial functions and opens the blood-brain/blood-glioma barrier.
Walter FR; Veszelka S; Pásztói M; Péterfi ZA; Tóth A; Rákhely G; Cervenak L; Ábrahám CS; Deli MA
J Neurochem; 2015 Sep; 134(6):1040-54. PubMed ID: 26112237
[TBL] [Abstract][Full Text] [Related]
4. Targeting classical but not neurogenic inflammation reduces peritumoral oedema in secondary brain tumours.
Lewis KM; Harford-Wright E; Vink R; Ghabriel MN
J Neuroimmunol; 2012 Sep; 250(1-2):59-65. PubMed ID: 22722013
[TBL] [Abstract][Full Text] [Related]
5. Early blood-brain barrier disruption after high-dose single-fraction irradiation in rats.
Nakata H; Yoshimine T; Murasawa A; Kumura E; Harada K; Ushio Y; Hayakawa T
Acta Neurochir (Wien); 1995; 136(1-2):82-6; discussion 86-7. PubMed ID: 8748832
[TBL] [Abstract][Full Text] [Related]
6. Effect of intracarotid infusion of etoposide: modification of the permeability of the blood-brain barrier and the blood-tumor barrier in rat brain tumor model.
Maeda Y; Matsumoto K; Mizumatsu S; Tamiya T; Furuta T; Ohmoto T
Acta Med Okayama; 1999 Feb; 53(1):5-11. PubMed ID: 10096732
[TBL] [Abstract][Full Text] [Related]
7. Examination of blood-brain barrier (BBB) integrity in a mouse brain tumor model.
On NH; Mitchell R; Savant SD; Bachmeier CJ; Hatch GM; Miller DW
J Neurooncol; 2013 Jan; 111(2):133-43. PubMed ID: 23184143
[TBL] [Abstract][Full Text] [Related]
8. Changes of the blood-brain barrier in experimental metastatic brain tumors.
Hasegawa H; Ushio Y; Hayakawa T; Yamada K; Mogami H
J Neurosurg; 1983 Aug; 59(2):304-10. PubMed ID: 6864299
[TBL] [Abstract][Full Text] [Related]
9. VLA-4 mediated adhesion of melanoma cells on the blood-brain barrier is the critical cue for melanoma cell intercalation and barrier disruption.
García-Martín AB; Zwicky P; Gruber T; Matti C; Moalli F; Stein JV; Francisco D; Enzmann G; Levesque MP; Hewer E; Lyck R
J Cereb Blood Flow Metab; 2019 Oct; 39(10):1995-2010. PubMed ID: 29762071
[TBL] [Abstract][Full Text] [Related]
10. Cold-injury of the cerebral cortex: immunolocalization of cellular proteins and blood-brain barrier permeability studies.
Nag S
J Neuropathol Exp Neurol; 1996 Aug; 55(8):880-8. PubMed ID: 8759777
[TBL] [Abstract][Full Text] [Related]
11. The proinflammatory peptide substance P promotes blood-brain barrier breaching by breast cancer cells through changes in microvascular endothelial cell tight junctions.
Rodriguez PL; Jiang S; Fu Y; Avraham S; Avraham HK
Int J Cancer; 2014 Mar; 134(5):1034-44. PubMed ID: 23934616
[TBL] [Abstract][Full Text] [Related]
12. Focal cerebral ischemic tolerance and change in blood-brain barrier permeability after repetitive pure oxygen exposure preconditioning in a rodent model.
Wang X; Kang K; Wang S; Yao J; Zhang X
J Neurosurg; 2016 Oct; 125(4):943-952. PubMed ID: 26824373
[TBL] [Abstract][Full Text] [Related]
13. Reduced blood brain barrier breakdown in P-selectin deficient mice following transient ischemic stroke: a future therapeutic target for treatment of stroke.
Jin AY; Tuor UI; Rushforth D; Kaur J; Muller RN; Petterson JL; Boutry S; Barber PA
BMC Neurosci; 2010 Feb; 11():12. PubMed ID: 20122276
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of substance P transport across the blood-brain barrier.
Chappa AK; Audus KL; Lunte SM
Pharm Res; 2006 Jun; 23(6):1201-8. PubMed ID: 16729222
[TBL] [Abstract][Full Text] [Related]
15. Permeability characteristics of brain adjacent to tumors in rats.
Levin VA; Freeman-Dove M; Landahl HD
Arch Neurol; 1975 Dec; 32(12):785-91. PubMed ID: 1203030
[TBL] [Abstract][Full Text] [Related]
16. The potential for substance P antagonists as anti-cancer agents in brain tumours.
Harford-Wright E; Lewis KM; Vink R
Recent Pat CNS Drug Discov; 2013 Apr; 8(1):13-23. PubMed ID: 23477306
[TBL] [Abstract][Full Text] [Related]
17. Structural pathways for macromolecular and cellular transport across the blood-brain barrier during inflammatory conditions. Review.
Lossinsky AS; Shivers RR
Histol Histopathol; 2004 Apr; 19(2):535-64. PubMed ID: 15024715
[TBL] [Abstract][Full Text] [Related]
18. Acute effects of human recombinant tumor necrosis factor-alpha on the cerebral vasculature of the rat in both normal brain and in an experimental glioma model.
Kido G; Wright JL; Merchant RE
J Neurooncol; 1991 Apr; 10(2):95-109. PubMed ID: 1716671
[TBL] [Abstract][Full Text] [Related]
19. Effects of glucocorticoid and chemotherapy on the peritumoral edema and astrocytic reaction in experimental brain tumor.
Jamshidi J; Yoshimine T; Ushio Y; Hayakawa T
J Neurooncol; 1992 Mar; 12(3):197-204. PubMed ID: 1583554
[TBL] [Abstract][Full Text] [Related]
20. Negative correlation of CD34+ cells with blood-brain barrier permeability following traumatic brain injury in a rat model.
Jin X; Wang F; Liu X; Liang B; Chen Z; He J; Zhang H; Zhang J
Microcirculation; 2014 Nov; 21(8):696-702. PubMed ID: 24894113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
